MAKERS of the fat jab Wegovy say they will not increase the price of the drug when the cost of rival Mounjaro doubles next ...

Mounjaro, one of the UK’s most popular weight-loss jabs, is set to become more expensive for private patients after Eli Lilly ...

Many Mounjaro users are looking into alternative medications following news of a 170 percent price increase in the UK ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Yesterday, US pharmaceutical giant Lilly announced the cost would soar from September 1, with a month's supply of the highest ...

More than a million Britons are now injecting themselves weekly with drugs-bought online or through private clinics-lured by ...

At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions ...

A 2025 survey highlights growing momentum for multi-indication drug development, with opportunities in innovative trial ...

SELF-confessed “secret eater” Emilly Murray weighed 22st 2lbs and was struggling to squeeze into size 30 clothes. Now a svelte 10st 10lbs and wearing a size eight, the 35-year-old ...

Republican leaders pushed back on the DHHS approach. They also tied the dispute to broader state budget negotiations.

The survey of 2,000 weight loss patients found that a doubling in price would see 80% coming off Mounjaro, with 51% switching ...

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.